Koru Medical Systems Inc (KRMD)

$5.52 -0.17 (-2.99%)
Market Cap 249.68M
Revenue (ttm) 33.65M
Net Income (ttm) -6.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.04%
Debt to Equity Ratio 0.00
Volume 1,354,200
Avg Vol 184,670
Day's Range N/A - N/A
Shares Out 46.32M
Stochastic %K 70%
Beta 0.51
Analysts Strong Sell
Price Target $6.60

Company Profile

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobin...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 845-469-2042
Fax: 845 469 5518
Address:
100 Corporate Drive, Mahwah, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 2 at 5:59 PM
$KRMD RSI: 39.01, MACD: -0.0313 Vol: 0.12, MA20: 5.62, MA50: 5.65 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
copywrites
copywrites Jan. 29 at 9:22 PM
$KRMD really good news! congratulations 🎉
0 · Reply
Gesundheit
Gesundheit Jan. 20 at 7:48 AM
$KRMD I have been with KRMD since 2020. Very predictable. There will be down pressure for a while since next earnings is not till March even though they have already spilled the beans that it will be good. Funds are wanting in but at a better price. Anything in the $5.00 range should work well if you are looking to hold long.
0 · Reply
Paper_Route_Frank
Paper_Route_Frank Jan. 17 at 1:15 PM
$KRMD avg 5.73 light position
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 7 at 12:47 AM
$KRMD RSI: 45.63, MACD: 0.1493 Vol: 0.28, MA20: 5.86, MA50: 5.08 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Dec. 31 at 6:17 PM
Big move for $KRMD — oncology expansion just got real. ⚠️💡 KORU Medical filed a 510(k) to use the FreedomEDGE System for subcutaneous PHESGO delivery, expanding into oncology while aiming to simplify breast cancer care. See why this regulatory step matters 👉 https://www.zacks.com/stock/news/2810902/krmd-submits-510k-to-use-freedomedge-system-with-oncology-biologic?cid=sm-stocktwits-2-2810902-teaser-27048&ADID=SYND_STOCKTWITS_TWEET_2_2810902_TEASER_27048
0 · Reply
ZacksResearch
ZacksResearch Dec. 31 at 5:17 PM
$KRMD saw a 6.1% decline following the announcement of a major FDA filing! 📉 KORU Medical submits a 510(k) for its FreedomEDGE system to deliver PHESGO subcutaneously, aiming to simplify cancer treatment and expand its market in oncology. Understand the strategic impact here 👉 https://www.zacks.com/stock/news/2810902/krmd-submits-510k-to-use-freedomedge-system-with-oncology-biologic?cid=sm-stocktwits-2-2810902-body-27038&ADID=SYND_STOCKTWITS_TWEET_2_2810902_BODY_27038
0 · Reply
copywrites
copywrites Dec. 31 at 6:22 AM
$KRMD PHESGO here we come, Roche Drug onboarding ✅
0 · Reply
Gesundheit
Gesundheit Dec. 30 at 3:15 PM
$KRMD Another dip, buy point coming up. :)
0 · Reply
ThesisTrader
ThesisTrader Dec. 25 at 9:44 AM
$KRMD Forward momentum is increasingly dictated by operational clarity, amid evolving funding conditions and shifting competitive responses. Clear follow‑through could unlock sustainable re‑rating.
0 · Reply
Latest News on KRMD
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

Jan 29, 2026, 4:05 PM EST - 5 days ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow

Jan 12, 2026, 8:00 AM EST - 22 days ago

KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jan 5, 2026, 7:00 AM EST - 4 weeks ago

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

Dec 30, 2025, 4:05 PM EST - 5 weeks ago

KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic

KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer

Dec 16, 2025, 4:05 PM EST - 7 weeks ago

KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

Nov 17, 2025, 4:05 PM EST - 2 months ago

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

KORU Medical Systems to Participate in Upcoming Investor Conferences

Nov 13, 2025, 8:00 AM EST - 2 months ago

KORU Medical Systems to Participate in Upcoming Investor Conferences

KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 8:41 PM EST - 2 months ago

KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

Nov 12, 2025, 4:05 PM EST - 2 months ago

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

Nov 4, 2025, 4:05 PM EST - 3 months ago

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 22, 2025, 4:05 PM EDT - 3 months ago

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Sep 18, 2025, 8:00 AM EDT - 4 months ago

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Cirtec Medical Announces Appointment of New Chief Executive Officer

Aug 28, 2025, 12:59 PM EDT - 5 months ago

Cirtec Medical Announces Appointment of New Chief Executive Officer

KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:23 AM EDT - 6 months ago

KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

Aug 6, 2025, 4:05 PM EDT - 6 months ago

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 30, 2025, 4:05 PM EDT - 6 months ago

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 16, 2025, 4:05 PM EDT - 7 months ago

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

Jul 7, 2025, 4:05 PM EDT - 7 months ago

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

Jun 11, 2025, 4:05 PM EDT - 8 months ago

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript

May 11, 2025, 8:12 AM EDT - 9 months ago

KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

May 7, 2025, 4:05 PM EDT - 9 months ago

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 10:34 PM EDT - 11 months ago

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

Mar 12, 2025, 4:05 PM EDT - 11 months ago

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Feb 19, 2025, 4:05 PM EST - 1 year ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

KORU Medical Systems Has A Long Runway

Feb 10, 2025, 12:11 AM EST - 1 year ago

KORU Medical Systems Has A Long Runway

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Feb 6, 2025, 4:05 PM EST - 1 year ago

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Jan 30, 2025, 4:05 PM EST - 1 year ago

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

Jan 13, 2025, 8:00 AM EST - 1 year ago

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 25, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:57 PM EST - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Nov 13, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Impressive Turnaround At KORU Medical

Nov 6, 2024, 8:34 AM EST - 1 year ago

Impressive Turnaround At KORU Medical

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

Oct 31, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

Oct 23, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Sep 5, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:52 PM EDT - 1 year ago

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

Aug 7, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jul 25, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

Jul 24, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 17, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Jul 2, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Jun 5, 2024, 9:00 AM EDT - 1 year ago

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

Jun 4, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

May 14, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

May 1, 2024, 10:11 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

May 1, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 17, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Apr 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

Mar 18, 2024, 5:24 PM EDT - 2 years ago

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 8:27 PM EDT - 2 years ago

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 2 at 5:59 PM
$KRMD RSI: 39.01, MACD: -0.0313 Vol: 0.12, MA20: 5.62, MA50: 5.65 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
copywrites
copywrites Jan. 29 at 9:22 PM
$KRMD really good news! congratulations 🎉
0 · Reply
Gesundheit
Gesundheit Jan. 20 at 7:48 AM
$KRMD I have been with KRMD since 2020. Very predictable. There will be down pressure for a while since next earnings is not till March even though they have already spilled the beans that it will be good. Funds are wanting in but at a better price. Anything in the $5.00 range should work well if you are looking to hold long.
0 · Reply
Paper_Route_Frank
Paper_Route_Frank Jan. 17 at 1:15 PM
$KRMD avg 5.73 light position
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 7 at 12:47 AM
$KRMD RSI: 45.63, MACD: 0.1493 Vol: 0.28, MA20: 5.86, MA50: 5.08 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Dec. 31 at 6:17 PM
Big move for $KRMD — oncology expansion just got real. ⚠️💡 KORU Medical filed a 510(k) to use the FreedomEDGE System for subcutaneous PHESGO delivery, expanding into oncology while aiming to simplify breast cancer care. See why this regulatory step matters 👉 https://www.zacks.com/stock/news/2810902/krmd-submits-510k-to-use-freedomedge-system-with-oncology-biologic?cid=sm-stocktwits-2-2810902-teaser-27048&ADID=SYND_STOCKTWITS_TWEET_2_2810902_TEASER_27048
0 · Reply
ZacksResearch
ZacksResearch Dec. 31 at 5:17 PM
$KRMD saw a 6.1% decline following the announcement of a major FDA filing! 📉 KORU Medical submits a 510(k) for its FreedomEDGE system to deliver PHESGO subcutaneously, aiming to simplify cancer treatment and expand its market in oncology. Understand the strategic impact here 👉 https://www.zacks.com/stock/news/2810902/krmd-submits-510k-to-use-freedomedge-system-with-oncology-biologic?cid=sm-stocktwits-2-2810902-body-27038&ADID=SYND_STOCKTWITS_TWEET_2_2810902_BODY_27038
0 · Reply
copywrites
copywrites Dec. 31 at 6:22 AM
$KRMD PHESGO here we come, Roche Drug onboarding ✅
0 · Reply
Gesundheit
Gesundheit Dec. 30 at 3:15 PM
$KRMD Another dip, buy point coming up. :)
0 · Reply
ThesisTrader
ThesisTrader Dec. 25 at 9:44 AM
$KRMD Forward momentum is increasingly dictated by operational clarity, amid evolving funding conditions and shifting competitive responses. Clear follow‑through could unlock sustainable re‑rating.
0 · Reply
HaikuHustle
HaikuHustle Dec. 24 at 11:57 AM
$KRMD Current positioning will be tested as operational decisions reinforce credibility with the market. Confidence improves only with repeatable results.
0 · Reply
Gesundheit
Gesundheit Dec. 23 at 8:20 PM
$KRMD It broke out. Next stop $7.00
0 · Reply
copywrites
copywrites Dec. 23 at 5:04 PM
$KRMD i would like to repeat 👀
0 · Reply
copywrites
copywrites Dec. 22 at 3:35 PM
$KRMD i like 👀
0 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 3:18 PM
Lake Street has adjusted their stance on KORU Medical Systems ( $KRMD ), setting the rating to Buy with a target price of 6 → 8.
0 · Reply
DARKP00L
DARKP00L Dec. 17 at 8:28 PM
$KRMD 15:20 on Dec. 17 2025 Canaccord Genuity Maintains Buy on KORU Medical Systems, Raises Price Target to $6 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:21 PM
Canaccord Genuity has adjusted their stance on KORU Medical Systems ( $KRMD ), setting the rating to Buy with a target price of 5 → 6.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 17 at 1:53 PM
$KRMD Share Price: $5.75 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $0.93 – $1.14 Target Zone: $1.68 – $2.06 Potential Upside: 72% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
theDIOyears
theDIOyears Dec. 15 at 12:47 PM
$QIPT $XTNT $KRMD $XBI Done deal, at 3.65
0 · Reply
theDIOyears
theDIOyears Dec. 9 at 3:06 PM
$QIPT Large activist investors sending a loud message to the board. Im listening, are you? Have management sell at 3.10? Buy low, sell high. $XTNT $KRMD $XBI
0 · Reply
theDIOyears
theDIOyears Dec. 1 at 3:40 AM
$XTNT Yall see that they updated the Xtant Medical website? Under 0.60, bottom BOLL line. Ive been buying have you? Someone tell Trader to buy low, sell high for me. $XBI $KRMD
1 · Reply